Lahnborg G
Acta Chir Scand. 1980;146(5):319-22.
The effect of low doses of heparin (5000 units of sodium heparin every 12 hours for 10 days) and dihydroergotamine (DHE) (0.5 mg at the same intervals as heparin) on the incidence of deep-vein thrombosis (D.V.T.) in the legs was studied on 210 patients undergoing nailing of a fractured neck of the femur. The patients were allocated randomly to receive heparin (70 patients) or heparin + dihydroergotamine (71 patients) or saline (69 patients, acting as controls). D.V.T. developed in 15 patients in the heparin group, in 12 patients in heparin + DHE group and in 28 patients in the control group. There is a significant difference between the two groups receiving heparin on the one hand and the control group on the other. DHE does not seem to reduce the incidence of D.V.T. any further in this group of patients.
对210例接受股骨颈骨折穿钉术的患者,研究了低剂量肝素(每12小时5000单位肝素钠,共10天)和双氢麦角胺(DHE)(与肝素相同间隔给予0.5毫克)对腿部深静脉血栓形成(D.V.T.)发生率的影响。患者被随机分配接受肝素治疗(70例)或肝素+双氢麦角胺治疗(71例)或生理盐水治疗(69例,作为对照)。肝素组有15例发生D.V.T.,肝素+DHE组有12例发生D.V.T.,对照组有28例发生D.V.T.。一方面接受肝素治疗的两组与另一方面的对照组之间存在显著差异。在该组患者中,双氢麦角胺似乎并未进一步降低D.V.T.的发生率。